234 related articles for article (PubMed ID: 15292181)
1. Proliferation of neointimal smooth muscle cells after arterial injury. Dependence on interactions between fibroblast growth factor receptor-2 and fibroblast growth factor-9.
Agrotis A; Kanellakis P; Kostolias G; Di Vitto G; Wei C; Hannan R; Jennings G; Bobik A
J Biol Chem; 2004 Oct; 279(40):42221-9. PubMed ID: 15292181
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
Millette E; Rauch BH; Defawe O; Kenagy RD; Daum G; Clowes AW
Circ Res; 2005 Feb; 96(2):172-9. PubMed ID: 15625285
[TBL] [Abstract][Full Text] [Related]
3. Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saporin fusion protein.
Farb A; Lee SJ; Min DH; Parandoosh Z; Cook J; McDonald J; Pierce GF; Virmani R
Circ Res; 1997 Apr; 80(4):542-50. PubMed ID: 9118485
[TBL] [Abstract][Full Text] [Related]
4. Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.
Kornmann M; Lopez ME; Beger HG; Korc M
Int J Pancreatol; 2001; 29(2):85-92. PubMed ID: 11876253
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: relationships to neointima formation.
Wong J; Rauhöft C; Dilley RJ; Agrotis A; Jennings GL; Bobik A
Circulation; 1997 Sep; 96(5):1631-40. PubMed ID: 9315558
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis-dependent and independent phases of intimal hyperplasia.
Khurana R; Zhuang Z; Bhardwaj S; Murakami M; De Muinck E; Yla-Herttuala S; Ferrara N; Martin JF; Zachary I; Simons M
Circulation; 2004 Oct; 110(16):2436-43. PubMed ID: 15477408
[TBL] [Abstract][Full Text] [Related]
7. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN.
Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC
Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145
[TBL] [Abstract][Full Text] [Related]
8. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
[TBL] [Abstract][Full Text] [Related]
9. Suppression of c-Cbl tyrosine phosphorylation inhibits neointimal formation in balloon-injured rat arteries.
Tang Z; Wang Y; Fan Y; Zhu Y; Chien S; Wang N
Circulation; 2008 Aug; 118(7):764-72. PubMed ID: 18663086
[TBL] [Abstract][Full Text] [Related]
10. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
Hughes SE
Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
[TBL] [Abstract][Full Text] [Related]
11. RNA interference for discoidin domain receptor 2 attenuates neointimal formation in balloon injured rat carotid artery.
Shyu KG; Wang BW; Kuan P; Chang H
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1447-53. PubMed ID: 18497308
[TBL] [Abstract][Full Text] [Related]
12. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.
Banai S; Wolf Y; Golomb G; Pearle A; Waltenberger J; Fishbein I; Schneider A; Gazit A; Perez L; Huber R; Lazarovichi G; Rabinovich L; Levitzki A; Gertz SD
Circulation; 1998 May; 97(19):1960-9. PubMed ID: 9609090
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.
Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A
Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing of fibroblast growth factor receptors in human prostate cancer.
Kwabi-Addo B; Ropiquet F; Giri D; Ittmann M
Prostate; 2001 Feb; 46(2):163-72. PubMed ID: 11170144
[TBL] [Abstract][Full Text] [Related]
15. Signaling through fibroblast growth factor receptor 2b plays a key role in the development of the exocrine pancreas.
Miralles F; Czernichow P; Ozaki K; Itoh N; Scharfmann R
Proc Natl Acad Sci U S A; 1999 May; 96(11):6267-72. PubMed ID: 10339576
[TBL] [Abstract][Full Text] [Related]
16. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
[TBL] [Abstract][Full Text] [Related]
17. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
Lopez ME; Korc M
J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.
Berry D; Shriver Z; Natke B; Kwan CP; Venkataraman G; Sasisekharan R
Biochem J; 2003 Jul; 373(Pt 1):241-9. PubMed ID: 12659634
[TBL] [Abstract][Full Text] [Related]
19. Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.
Cai Y; Nagel DJ; Zhou Q; Cygnar KD; Zhao H; Li F; Pi X; Knight PA; Yan C
Circ Res; 2015 Mar; 116(7):1120-32. PubMed ID: 25608528
[TBL] [Abstract][Full Text] [Related]
20. Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2.
Scotet E; Houssaint E
Oncogene; 1998 Jul; 17(1):67-76. PubMed ID: 9671315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
